CN114105955A - Fluorospirotriphenylamine derivative compound and preparation method and application thereof - Google Patents

Fluorospirotriphenylamine derivative compound and preparation method and application thereof Download PDF

Info

Publication number
CN114105955A
CN114105955A CN202111557329.4A CN202111557329A CN114105955A CN 114105955 A CN114105955 A CN 114105955A CN 202111557329 A CN202111557329 A CN 202111557329A CN 114105955 A CN114105955 A CN 114105955A
Authority
CN
China
Prior art keywords
reaction
spiro
fluorene
derivative
triphenylamine derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202111557329.4A
Other languages
Chinese (zh)
Inventor
郑明辉
陈文铖
籍少敏
霍延平
伍昱岚
陈绍鸿
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangdong University of Technology
Original Assignee
Guangdong University of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangdong University of Technology filed Critical Guangdong University of Technology
Priority to CN202111557329.4A priority Critical patent/CN114105955A/en
Publication of CN114105955A publication Critical patent/CN114105955A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1007Non-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1059Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms

Abstract

The invention discloses a fluorine spiro triphenylamine derivative compound, a preparation method and application thereof, and the structural formula is
Figure DDA0003419426610000011
The structure is based on that triphenyltriazine is used as electron withdrawing and triphenylamine is used as electron donating, and a series of organic light-emitting small molecules of the fluorene spiro triphenylamine derivative are prepared by introducing groups with different steric hindrance into the ortho position of triazine; the fluorene spiro triphenylamine derivative has good luminous intensity and extremely high fluorescence quantum yield; the steric effect is used for regulating and controlling the excited state configuration change and non-radiative transition of the molecule, so that the molecule realizes high efficiency; can be used as a novel luminescent molecule with good performance, low cost and high luminous intensity; the fluorine spiro triphenylamine derivative compound has obvious economic value in the aspects of preparing luminescent materials, luminescent devices or intelligent materials and the like, and has full-color display and solidHas good application prospect in the field of status illumination.

Description

Fluorospirotriphenylamine derivative compound and preparation method and application thereof
Technical Field
The invention relates to the field of organic luminescent materials, in particular to a fluorene spiro triphenylamine derivative compound and a preparation method thereof.
Background
The technology of using organic light emitting materials as Organic Light Emitting Diodes (OLEDs) has wide applications in the fields of flat panel displays, smart phones, solid state lighting, and the like, owing to the significant advantages of large area and high quality display and lighting, ultrahigh resolution, ultra-fast response speed, flexibility, and the like. The method has great application potential in the fields of flat panel display, smart phones, solid luminescence and the like, and attracts wide attention of the global academic and industrial fields.
However, the performance of the exciplex-based OLED devices still falls far behind devices using conventional D-. pi. -A-type TADF materials or phosphorescent emitters. The low electroluminescent efficiency is associated with its low photoluminescence quantum efficiency (PLQY), which is a long-standing unsolved problem in such systems and has significant limitations for their future development and application.
Disclosure of Invention
The invention aims to overcome the problems of low efficiency and the like of the prior art and provides a fluorene spiro triphenylamine derivative compound subjected to different modifications, wherein the provided fluorene spiro triphenylamine derivative compound can be used as an organic luminescent material, and realizes a qualitative breakthrough in device efficiency and roll-off by adjusting the excited state configuration change of molecules and inhibiting non-radiative transition.
Another object of the present invention is to provide a method for preparing the above-mentioned fluorene spiro triphenylamine derivative compound.
In order to solve the technical problems, the invention adopts the technical scheme that:
a fluorene spiro triphenylamine derivative compound has a molecule shown as a formula (I):
Figure BDA0003419426590000011
wherein R is a substituent group independently selected from the following structural formulas:
Figure BDA0003419426590000021
one kind of (1).
The invention connects donor and acceptor units through rigid linked fluorene and introduces large steric hindrance groups at the ortho position of the acceptor, thereby limiting the donor and acceptor units in close-packed coplanar configuration, thereby controlling the change of excited state configuration of molecules and inhibiting non-radiative transition so as to realize high efficiency. A strong electron coupling between the donor and acceptor cell is also sufficient to allow efficient direct absorption of the CT state. Rigid exciplex emitters have more efficient emission than more flexible or less coupled conventional exciplexes and conventional pi-linked TADF molecules.
Therefore, the fluorene spiro triphenylamine derivative compound provided by the invention can be used as a luminescent material or an intelligent material, and has a good application prospect in the fields of full-color display and solid-state lighting.
Preferably, said R is independently selected from the following structural formulae:
Figure BDA0003419426590000022
one kind of (1).
The structural formula of the fluorene spiro triphenylamine derivative compound is shown as the following benezen I:
Figure BDA0003419426590000023
Figure BDA0003419426590000031
the invention also provides a preparation method of the fluorene spiro triphenylamine derivative compound, which comprises the following steps:
s1, preparing a corresponding iodo product from a benzoic acid derivative, iodobenzene diacetic acid and iodine under the action of palladium acetate;
s2, performing hydrolysis reaction on the iodo product prepared in the step S1 and methyl iodide to obtain a corresponding esterified product;
s3, preparing a corresponding biphenyl product by a Suzuki reaction of the esterification product prepared in the step S2 and pinacol ester phenylboronic acid under the action of tetratriphenylphosphine palladium;
s4, carrying out cyclization reaction on the biphenyl product obtained in the step S3 in methanesulfonic acid to obtain the corresponding fluorenone derivative.
S5, mixing the fluorenone derivative prepared in the step S4 and 2, 4-diphenyl-6- [4- (4,4,5, 5-tetramethyl-1, 3, 2-dioxaborolan-2-yl) phenyl]Under the action of palladium tetratriphenylphosphine, the intermediate a is prepared by Suzuki reaction of-1, 3, 5-triazine
Figure BDA0003419426590000032
S6, reacting the intermediate a prepared in the step S5 with 2-bromotriphenylamine at low temperature through n-butyl lithium to prepare the fluorene spirotriphenylamine derivative
Figure BDA0003419426590000033
The benzoic acid derivative is
Figure BDA0003419426590000034
Preferably, the molar ratio of the benzoic acid derivative, the iodobenzene diacetic acid and the iodine in the step S1 is 1 (1-1.3) to 1-1.3.
Preferably, the iodination reaction temperature in the step S1 is 90-110 ℃, and the reaction time is 16-24 h.
Preferably, in step S1, the organic solvent for reaction is one of toluene, dimethyl sulfoxide and N, N-dimethylformamide.
Preferably, the molar ratio of the iodo product prepared in the step S2 in the S1 to methyl iodide is 1 (1.5-2).
Preferably, in the step S2, the hydrolysis reaction temperature is 60-90 ℃, and the reaction time is 3-6 h.
Preferably, the step S3Suzuki reaction shows that the molar ratio of the esterification product prepared by the step S2 to the pinacol ester of phenylboronic acid is 1: 1.1.
preferably, the Suzuki reaction temperature in the step S3 is 40-60 ℃, and the reaction time is 6-8 h.
Preferably, the inorganic base in the step S3Suzuki reaction is potassium carbonate.
Preferably, in step S3, the organic solvent for reaction is one of toluene, tetrahydrofuran and N, N-dimethylformamide.
Preferably, the temperature of the ring-closure reaction in the step S4 is 60-90 ℃, and the reaction time is 6-10 h.
Preferably, the molar ratio of the fluorenone derivative prepared in the step S5 or S4 to 2, 4-diphenyl-6- [4- (4,4,5, 5-tetramethyl-1, 3, 2-dioxaborolan-2-yl) phenyl ] -1,3, 5-triazine is 1: (1.1-1.3).
Preferably, in step S5, the organic solvent for reaction is one of toluene, tetrahydrofuran and N, N-dimethylformamide.
Preferably, in the step S5, the Suzuki reaction is performed at a temperature of 100 to 130 ℃ for 16 to 24 hours in an inert gas atmosphere.
Preferably, in step S5, the reacted alkali salt is one of sodium carbonate, potassium carbonate and cesium carbonate.
Preferably, in the step S6, the molar ratio of the intermediate a, 2-bromotriphenylamine and n-butyl lithium prepared in the step S5 is: 1: 1.2: 1.32.
preferably, in the step S6, the reaction is carried out for 1h at-78 ℃ under an inert gas atmosphere.
The fluorene spiro triphenylamine derivative compound is applied to luminescent materials, luminescent devices or intelligent materials and the like.
Compared with the prior art, the invention has the beneficial effects that:
the technical scheme provided by the invention connects a donor unit and an acceptor unit through rigid linked fluorene, and introduces a large steric hindrance group at the ortho position of the acceptor, so that the donor unit and the acceptor unit are limited in a close-packed coplanar configuration, thereby controlling the change of the excited state configuration of the molecule to enhance the RISC rate, and in addition, the nonradiative transition can be inhibited, so as to realize high efficiency. A strong electron coupling between the donor and acceptor cell is also sufficient to allow efficient direct absorption of the CT state.
Rigid exciplex emitters have very high PLQE when incorporated into a solid matrix, over 90%, compared to more flexible or less coupled traditional exciplexes. And has a similar delta E than conventional pi-linked TADF moleculesSTWhile at the same time having a faster RISC rate. Therefore, the invention has good application prospect in the fields of full-color display and solid-state lighting as a luminescent material or an intelligent material.
Drawings
FIG. 1 is a NMR spectrum of compound M1 prepared in example 1 of the present invention;
FIG. 2 is a mass spectrum of compound M1 prepared in example 1 of the present invention;
FIG. 3 is a nuclear magnetic resonance hydrogen spectrum of compound M2 prepared in example 2 of the present invention
FIG. 4 is a mass spectrum of compound M2 prepared in example 2 of the present invention;
FIG. 5 shows that the compound M1 prepared in example 1 of the present invention is at 1.0X 10-5Ultraviolet absorption spectrum in dichloromethane solution of M;
FIG. 6 shows that the compound M1 prepared in example 1 of the present invention is at 1.0X 10-5Fluorescence emission spectrum in toluene solution of M;
FIG. 7 shows that the compound M2 prepared in example 2 of the present invention is at 1.0X 10-5Ultraviolet absorption spectrum in dichloromethane solution of M;
FIG. 8 shows that the compound M2 prepared in example 2 of the present invention is at 1.0X 10-5Fluorescence emission spectrum in toluene solution of M.
Detailed Description
The present invention will be further described with reference to specific embodiments, but the present invention is not limited to the examples in any way. The starting reagents employed in the examples of the present invention are, unless otherwise specified, those that are conventionally purchased.
Example 1
This example provides a spirotriphenylamine derivative compound with a structural formula shown as M1:
Figure BDA0003419426590000051
the preparation method of the compound comprises the following steps:
Figure BDA0003419426590000061
s1.preparation of 2-chloro-4-iodo- [1,1' -biphenyl ] -3-carboxylic acid:
in a 250mL flask, 2-bromo-3-methylbenzoic acid (4.59g, 21.3mmol), palladium acetate (0.24g, 1.06mmol), iodobenzene diacetic acid (6.68g, 21.3mmol) and iodine (5.42g, 21.3mmol) were dissolved in N, N-dimethylformamide (50 mL). After stirring at 100 ℃ for 24h, the reaction mixture was cooled to room temperature and diluted with 50ml of ethyl acetate, 200ml of aqueous hydrochloric acid (0.5N) was added to wash off the N, N-dimethylformamide, and the crude product was extracted 3 times with ethyl acetate. The organic phase was collected, washed with saturated brine, and dried over anhydrous sodium sulfate. Vacuum concentrating for 30min at 0-700 mbar by a rotary evaporator, removing organic solvent, and purifying the residue by silica gel column chromatography to obtain white solid iodinated product 2-chloro-4-iodo- [1,1' -biphenyl ] -3-carboxylic acid 6.71 g. (yield: 85%)
S2.2-chloro-4-iodo- [1,1' -biphenyl ] -3-carboxylic acid methyl ester preparation;
2-chloro-4-iodo- [1,1' -biphenyl ] -3-carboxylic acid (6.71g, 18.8mmol) was dissolved in acetone (50.0mL), and potassium carbonate (5.2g, 37.6mmol) and iodomethane (4g, 28.2mmol) were added in this order. The reaction mixture was reacted under reflux for 3h and then quenched with water. Extracting the crude product with ethyl acetate for 3 times, collecting an organic phase, washing the organic phase with brine, drying the organic phase with anhydrous sodium sulfate, performing vacuum concentration for 30min at 0-700 mbar by using a rotary evaporator, and removing an organic solvent to obtain 6.64g of a product, namely 2-chloro-4-iodo- [1,1' -biphenyl ] -3-carboxylic acid methyl ester. This material was used in the next reaction without further purification. (yield: 95%)
S3.3 ' -chloro- [1,1':4', 1' -terphenyl ] -2' -carboxylic acid methyl ester preparation;
in a two-necked flask with a reflux condenser, methyl 2-chloro-4-iodo- [1,1' -biphenyl ] -3-carboxylate (6.64g, 17.9mmol), phenylboronic acid (2.2g, 17.9mmol), palladium tetrakistriphenylphosphine (1.04g, 0.9mmol) and potassium carbonate (4.5g, 35.8mmol) were added, and N, N-dimethylformamide (50mL) and water (8mL) were further added to mix, and the system was evacuated and charged with nitrogen. The resulting mixture was stirred at 55 ℃ for 7 hours, cooled to room temperature, poured into saturated brine, and extracted with ethyl acetate 3 times. The organic layer was collected, and the collected organic layer was washed with saturated brine and then dried over anhydrous sodium sulfate. Concentrating in vacuum for 30min under 0-700 mbar by a rotary evaporator, removing the organic solvent, and purifying the residue by silica gel column chromatography to obtain 4.3g of oily product 3' -chloro- [1,1':4', 1' -terphenyl ] -2' -methyl carboxylate. (yield: 75%)
S4, preparing 1-chloro-2-phenyl-9H-fluorenone;
methyl 3 '-chloro- [1,1':4',1 "-terphenyl ] -2' -carboxylate (4.3g, 13.4mmol) was dissolved in methanesulfonic acid (10 ml). The reaction was stirred at 65 ℃ for 6 hours, then quenched with water and extracted 3 times with ethyl acetate. The organic layer was collected, washed with saturated brine, dried over anhydrous sodium sulfate, and concentrated in vacuo for 30min at 0 to 700mbar by a rotary evaporator to remove the organic solvent, to give 3.6g of 1-chloro-2-phenyl-9H-fluorenone as a yellow solid (yield: 92%).
S5.preparation of 1- (4- (4, 6-biphenyl-1, 3, 5-triazine-2-phenyl) -2-phenyl-9H-fluorenone:
in a two-necked flask, 1-chloro-2-phenyl-9H-fluorenone (3.6g, 12.4mmol), 2, 4-diphenyl-6- [4- (4,4,5, 5-tetramethyl-1, 3, 2-dioxaborolan-2-yl) phenyl ] -1,3, 5-triazine (6g, 13.7mmol), tetrakistriphenylphosphine palladium (0.7g, 0.62mmol), and cesium carbonate (8.1g, 24.8mmol) were added under a nitrogen atmosphere. N, N-dimethylformamide (40mL) and water (8mL) were added and the system was evacuated and purged with nitrogen. Then heated and refluxed in an oil bath at 110 ℃ for 24 hours, after the reaction is finished, cooled to room temperature, and filtered to obtain 6.3g of 1- (4- (4, 6-biphenyl-1, 3, 5-triazine-2-phenyl) -2-phenyl-9H-fluorenone as a yellow solid, which is directly used in the next step. (yield: 90%)
S6.1 ' - (4- (4, 6-biphenyl-1, 3, 5-triazine-2-phenyl) -2', 10-biphenyl-10H-fluorenes Spirotriphenylamine [ acridine-9, 9' -fluorene ] preparation:
in a two-necked flask, 2-bromotriphenylamine (4.4g, 13.5mmol) was dissolved in 50mL of dehydrated tetrahydrofuran under a nitrogen atmosphere. The mixture was cooled to-78 ℃ and held for 10 minutes. 2.4M n-butyllithium (6.2ml, 14.8mmol) was then added dropwise over 10 minutes and the mixture was stirred for a further 1h at-78 ℃. Thereafter, 1- (4- (4, 6-biphenyl-1, 3, 5-triazine-2-phenyl) -2-phenyl-9H-fluorenone (6.3g, 11.2mmol) was added, and after further reaction at-78 ℃ for 15min, the mixture was slowly warmed to room temperature and stirred overnight. Then 10mL of distilled water was added to quench the reaction. The mixture was concentrated under reduced pressure to remove tetrahydrofuran, then extracted 3 times with dichloromethane, which was removed under reduced pressure. The residue was dissolved in 30mL of acetic acid, followed by the addition of 3mL of hydrochloric acid. The mixture was stirred at 110 ℃ for 4 hours. After cooling to room temperature, the mixture was poured into 100mL of ice water and filtered to give the crude product. The crude product was purified by silica gel column chromatography to give 7.5g of 1' - (4- (4, 6-biphenyl-1, 3, 5-triazine-2-phenyl) -2', 10-biphenyl-10H-fluorenes spirotriphenylamine [ acridine-9, 9' -fluorene ] as a solid product. (yield: 85%)
Example 2
This example provides a spirofluorene triphenylamine derivative compound, which is prepared in the same manner as in example 1, except that in example 1, the benzoic acid derivative used in S1 is
Figure BDA0003419426590000081
The structural formula of the obtained fluorene spiro triphenylamine derivative compound M2 and M2 is shown in the specification.
Figure BDA0003419426590000082
Performance testing
Characterization and performance test were performed on the fluorene spiro triphenylamine derivative compounds M1 and M2 obtained in examples 1 and 2.
The test method is as follows:
and (3) detecting the structure of the compound: using a Bruker 400MHz superconducting nuclear magnetic resonance instrument, wherein a solvent used by MI is deuterated chloroform, and a solvent used by M2 is deuterated dimethyl sulfoxide;
mass spectrum detection: m1 obtained in example 1 and M2 obtained in example 2 were dissolved in dichloromethane to prepare a solution with a concentration of 1mg/mL, and mass spectrometry was performed using a Saimer flying Q active ultra high resolution quadrupole combined electrostatic field orbitrap LC MS.
And (3) ultraviolet absorption spectrum detection: using Shimadzu ultraviolet visible spectrophotometer UV-2700, the scanning range was
200~700nm;
And (3) emission spectrum detection: using a steady state/transient state fluorescence spectrometer (FLS980), the excitation wavelength was 285nm,
under the protection of nitrogen, the testing temperature is 300K.
The test results were as follows:
the molecular hydrogen spectrum of the fluorene spiro triphenylamine derivative compound M1 prepared in example 1 is shown in fig. 1. It can be seen that: 1H NMR (400MHz, CDCl3) δ 8.78,8.77,8.76,8.23,8.18,8.16,7.98,7.96,7.88,7.87,7.78,7.65,7.64,7.63,7.62,7.61,7.61,7.60,7.59,7.58,7.57,7.56,7.56,7.52,7.37,7.37,7.36,7.35,7.34,7.33,7.26,7.23,7.21,7.20,7.19,7.18,7.15,7.15, molecular hydrogen spectrum peaks can correspond to the target product one-to-one, and are reasonable in number; from the mass spectrum (FIG. 2), it can be seen that the relative molecular mass in the graph is 791.31705, plus one H, consistent with the relative molecular mass of the synthesized M1. The results of the nuclear magnetic resonance and mass spectrometry combined indicate that the product obtained in example 1 was M1.
The molecular hydrogen spectrum of the fluorene spiro triphenylamine derivative compound M2 prepared in example 2 is shown in fig. 3. It can be seen that: 1H NMR (400MHz, DMSO) δ 8.78,8.77,8.31,8.29,8.02,8.00,7.98,7.76,7.74,7.71,7.70,7.68,7.50,7.48,7.38,7.36,7.34,7.25,7.24,7.19,7.18,7.13,7.12,7.05,7.03,6.87,6.85,6.83,6.57,6.55,6.53,6.43,6.41,6.24,6.22,5.75,5.73,5.32,1.97, molecular hydrogen spectrum peaks can correspond to the target product one to one, in reasonable amounts; from the mass spectrum (FIG. 4), it can be seen that the relative molecular mass in the graph is 729.30039, plus one H, consistent with the relative molecular mass of the synthesized M2. The results of the nuclear magnetic and mass spectra were combined to show that the product obtained in example 2 was M2.
M1 and M2 obtained in example were dissolved in Tetrahydrofuran (THF) solution using Shimadzu ultraviolet-visible spectrophotometer UV-2700 to prepare 1X 10-3Diluting the mother liquor to 1 × 10-5The mol/L is tested.
FIG. 5 shows M1 at 1X 10 prepared in example 1-5Ultraviolet-visible absorption spectrum in mol/L dichloromethane. As can be seen from FIG. 5, the main absorption peak position of M1 was 278 nm.
FIG. 6 shows M2 at 1X 10 prepared in example 2-5Ultraviolet-visible absorption spectrum in mol/L dichloromethane. As can be seen from FIG. 6, the main absorption peak position of M2 was 278 nm.
Fluorescence emission spectroscopy was used: FLS980 fluorometer, M1 and M2 prepared in example were dissolved in Tetrahydrofuran (THF) to prepare 1X 10-3mol/L of the mother liquor, when tested, diluted to 1X 10-5mol/L。
FIG. 7 shows M1 at 1X 10 prepared in example 1-5Fluorescence emission spectrum in mol/L toluene. As can be seen from FIG. 7, the main emission peak position of M1 was 475 nm.
FIG. 8 shows M2 at 1X 10 prepared in example 2-5Fluorescence emission spectrum in mol/L toluene. From fig. 8, the main emission peak position of M1 is 497 nm.
In conclusion, the fluorene spiro triphenylamine derivative compound provided by the invention realizes blue light emission (M1 is blue light emission, and M2 is sky blue light emission), and can be used as a novel OLED light-emitting molecule with good performance and low cost. The fluorene spiro triphenylamine derivative compound has obvious economic value in the application aspects of preparing luminescent materials, luminescent devices or intelligent materials and the like, and has good application prospect in the fields of full-color display and solid-state lighting.
Meanwhile, the invention realizes the controllable preparation of the fluorene spiro triphenylamine derivative compound; the preparation cost is low, the raw material source is wide, large-scale production can be realized, and the method has wide commercialization prospect.

Claims (10)

1. A fluorine spiro triphenylamine derivative is characterized by having a molecular structure shown as a formula (I):
Figure FDA0003419426580000011
wherein R is a substituent group independently selected from the following structural formulas:
Figure FDA0003419426580000012
one kind of (1).
2. The fluorene spiro triphenylamine derivative of claim 1, wherein R is independently selected from the following structural formulas:
Figure FDA0003419426580000013
one kind of (1).
3. A method for producing a fluorene spiro triphenylamine derivative according to claim 1, comprising the steps of:
s1, preparing a corresponding iodo product from a benzoic acid derivative, iodobenzene diacetic acid and iodine under the catalytic action of palladium acetate;
s2, performing hydrolysis reaction on the iodo product prepared in the step S1 and methyl iodide to obtain a corresponding esterified product;
s3, preparing the esterification product obtained in the step S2 and a corresponding esterification product of biphenyl and a pinacol ester of phenylboronic acid through a Suzuki reaction under the action of palladium tetratriphenylphosphine;
s4, carrying out cyclization reaction on the biphenyl product obtained in the step S3 in methanesulfonic acid to obtain the corresponding fluorenone derivative.
S5, reacting the fluorenone derivative prepared in the step S4 and 2, 4-diphenyl-6- [4- (4,4,5, 5-tetramethyl-1, 3, 2-dioxaborolan-2-yl) phenyl ] -1,3, 5-triazine under the action of palladium tetratriphenylphosphine to prepare an intermediate a through a Suzuki reaction;
Figure FDA0003419426580000014
s6, reacting the intermediate a prepared in the step S5 with 2-bromotriphenylamine at-78 ℃ through n-butyl lithium to prepare the fluorene spirotriphenylamine derivative
Figure FDA0003419426580000021
The benzoic acid derivative is
Figure FDA0003419426580000022
4. The method for producing a fluorenylspirotriphenylamine derivative according to claim 2, wherein the molar ratio of the benzoic acid derivative to the iodophenylenediacetic acid to iodine in step S1 is 1: (1-1.2): (1-1.2), the reaction temperature is 90-110 ℃, and the reaction time is 15-24 h.
5. The method for preparing the fluorene spiro triphenylamine derivative according to claim 2, wherein in the step S2, the reaction temperature is 50-70 ℃ and the reaction time is 3-6 hours.
6. The method for preparing the fluorene spiro triphenylamine derivative according to claim 2, wherein in the step S3, the reaction temperature is 40-60 ℃ and the reaction time is 6-8 h.
7. The method for preparing the fluorene spiro triphenylamine derivative according to claim 2, wherein in the step S4, the reaction temperature is 60 to 100 ℃ and the reaction time is 6 to 9 hours.
8. The method for producing a fluorenylspirotriphenylamine derivative according to claim 2, wherein the molar ratio of the fluorenone derivative to 2, 4-diphenyl-6- [4- (4,4,5, 5-tetramethyl-1, 3, 2-dioxaborolan-2-yl) phenyl ] -1,3, 5-triazine in step S5 is 1: (1.1-1.3), the reaction temperature is 90-110 ℃, and the reaction time is 20-24 h.
9. The method for preparing a fluorene spirotriphenylamine derivative according to claim 2, wherein the molar ratio of the intermediate a to 2-bromotriphenylamine to n-butyllithium in step S6 is 1 (1-1.3): (1.3-1.4), the reaction is carried out at-78 ℃ for 1h in an inert gas atmosphere, and the reaction is transferred to room temperature overnight.
10. Use of the fluorene spiro triphenylamine derivative according to claim 1 in a luminescent material, a luminescent device or an intelligent material.
CN202111557329.4A 2021-12-18 2021-12-18 Fluorospirotriphenylamine derivative compound and preparation method and application thereof Pending CN114105955A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111557329.4A CN114105955A (en) 2021-12-18 2021-12-18 Fluorospirotriphenylamine derivative compound and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111557329.4A CN114105955A (en) 2021-12-18 2021-12-18 Fluorospirotriphenylamine derivative compound and preparation method and application thereof

Publications (1)

Publication Number Publication Date
CN114105955A true CN114105955A (en) 2022-03-01

Family

ID=80365488

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111557329.4A Pending CN114105955A (en) 2021-12-18 2021-12-18 Fluorospirotriphenylamine derivative compound and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN114105955A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114716376A (en) * 2022-05-05 2022-07-08 广东工业大学 Derivative compound based on sulfone electron acceptor and preparation method and application thereof
CN115232110A (en) * 2022-07-18 2022-10-25 广东工业大学 Fluorenone derivative with sandwich structure, preparation method thereof and organic light-emitting device
EP4307867A1 (en) * 2022-07-15 2024-01-17 Taizhou Guanyu Technology Co., Ltd. Light-emitting element

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017042770A1 (en) * 2016-07-28 2017-03-16 Universidad Tecnológica De Panamá Automatic needle threader
CN107406391A (en) * 2015-09-30 2017-11-28 株式会社Lg化学 Spiro-compound and the organic illuminating element for including it
US20180033966A1 (en) * 2015-02-10 2018-02-01 Duk San Neolux Co., Ltd. Novel compound for organic electric element, organic electric element using the same, and electronic device comprising same
CN111440122A (en) * 2020-04-30 2020-07-24 苏州大学 Thermally activated delayed fluorescence material and organic light emitting device

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180033966A1 (en) * 2015-02-10 2018-02-01 Duk San Neolux Co., Ltd. Novel compound for organic electric element, organic electric element using the same, and electronic device comprising same
CN107406391A (en) * 2015-09-30 2017-11-28 株式会社Lg化学 Spiro-compound and the organic illuminating element for including it
WO2017042770A1 (en) * 2016-07-28 2017-03-16 Universidad Tecnológica De Panamá Automatic needle threader
CN111440122A (en) * 2020-04-30 2020-07-24 苏州大学 Thermally activated delayed fluorescence material and organic light emitting device

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MATTHEW M. WEISS ET AL.: "Sulfonamides as Selective Nav 1.7 Inhibitors:Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities", 《J.MED.CHEM》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114716376A (en) * 2022-05-05 2022-07-08 广东工业大学 Derivative compound based on sulfone electron acceptor and preparation method and application thereof
EP4307867A1 (en) * 2022-07-15 2024-01-17 Taizhou Guanyu Technology Co., Ltd. Light-emitting element
CN115232110A (en) * 2022-07-18 2022-10-25 广东工业大学 Fluorenone derivative with sandwich structure, preparation method thereof and organic light-emitting device

Similar Documents

Publication Publication Date Title
CN114105955A (en) Fluorospirotriphenylamine derivative compound and preparation method and application thereof
CN111303010B (en) Organic room-temperature phosphorescent material containing imide structure, preparation method and application thereof
CN102229623A (en) Spirofluorene xanthene phosphine oxide electro-phosphorescent main materials and synthesis and application methods thereof
CN107722061B (en) Fluorenyl oxadiazole iridium complex and preparation method and application thereof
CN113149864B (en) Synthesis and application of thermal activity delay fluorescent material based on indeno [2,1-a ] indene condensed ring unit
CN111320615A (en) Small molecules based on S, S-dioxo-dibenzothiophene and phenanthroimidazole and application thereof in electroluminescent device
CN114478432B (en) Phenothiazine long-life organic room-temperature phosphorescent material containing haloalkyl chain, synthesis and application thereof
CN111423450B (en) Compound, display panel and display device
CN110862420B (en) Energy transfer luminescent material based on triplet donor material and acceptor material and application thereof
CN111057008B (en) D-A type excited proton transfer high-efficiency fluorescent material and preparation method and application thereof
CN114716376A (en) Derivative compound based on sulfone electron acceptor and preparation method and application thereof
CN113201022A (en) Small conjugated phosphorescent metal iridium (III) complex with isomer and preparation method and application thereof
CN108689986B (en) Anthracene luminescent material and preparation method and application thereof
CN111925391A (en) Organic long afterglow material containing triphenyl phosphine (oxide) and its preparation method and use method
CN113683601B (en) Diaza-benzo-fluoranthene compound and preparation method and application thereof
CN115181095B (en) Pyrimidine-based luminophore with fluorescence-delayed fluorescence-room temperature phosphorescence triple emission characteristics and preparation method thereof
CN114835752A (en) Phosphoryloxybenzonitrile compound and preparation method and application thereof
CN115073445B (en) Organic luminescent material based on selenohexanthrone and preparation method and application thereof
CN115819281B (en) Cyano-substituted p-phenylene ethylene derivative, preparation method and application
CN114773292B (en) Organic single-molecule double-emission material based on phenothiazine, and preparation and application thereof
CN117003753A (en) Carbonyl arylamine pi stacking fluorescent dye and preparation method thereof
CN112707906B (en) Novel organic electroluminescent material based on benzopyrrole diketone and application thereof
CN115490631B (en) Near-infrared thermal activation delayed fluorescence luminescent material based on dicyanophenalene and application thereof
CN108047087A (en) 3 '-(4- bromonaphthalene -1- bases) [1,1 '-xenyl] -4- nitriles and its synthetic method
CN116987120A (en) Phosphine-containing multi-resonance aryl boron compound and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination